doi:10.1007/s00213-021-05789-9 82 Nery, F
1-2 (They are also known to cause hair loss, tachycardia, hypoglycemia, diarrhea and/or constipation, nausea and vomiting, gastroparesis, bowel obstructions, thyroid C-cell tumors, acute kidney injuries, gallbladder problems and pancreatitis.) 3-4 A 2025 case study highlights a healthy patient who, after a month of liraglutide therapy, developed NAION despite lacking common cardiovascular risk factors, underscoring that this adverse effect can manifest even in low-risk individuals
Unlike many traditional fat-loss compounds, it is being researched as a non-stimulant option, making it appealing for those who prefer a more balanced and controlled approach to metabolic support
L.MurphyK